6-64307084-TGAGAGAGAGAGA-TGAGAGAGAGA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001142800.2(EYS):c.6079-4_6079-3delTC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.544 in 860,580 control chromosomes in the GnomAD database, including 81,349 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.68 ( 34426 hom., cov: 0)
Exomes 𝑓: 0.52 ( 46923 hom. )
Consequence
EYS
NM_001142800.2 splice_region, intron
NM_001142800.2 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.762
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 6-64307084-TGA-T is Benign according to our data. Variant chr6-64307084-TGA-T is described in ClinVar as [Benign]. Clinvar id is 196616.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-64307084-TGA-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.7 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EYS | NM_001142800.2 | c.6079-4_6079-3delTC | splice_region_variant, intron_variant | ENST00000503581.6 | NP_001136272.1 | |||
EYS | NM_001292009.2 | c.6079-4_6079-3delTC | splice_region_variant, intron_variant | NP_001278938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EYS | ENST00000503581.6 | c.6079-4_6079-3delTC | splice_region_variant, intron_variant | 5 | NM_001142800.2 | ENSP00000424243.1 | ||||
EYS | ENST00000370621.7 | c.6079-4_6079-3delTC | splice_region_variant, intron_variant | 1 | ENSP00000359655.3 |
Frequencies
GnomAD3 genomes AF: 0.680 AC: 101866AN: 149726Hom.: 34406 Cov.: 0
GnomAD3 genomes
AF:
AC:
101866
AN:
149726
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.551 AC: 51515AN: 93566Hom.: 6275 AF XY: 0.546 AC XY: 27027AN XY: 49492
GnomAD3 exomes
AF:
AC:
51515
AN:
93566
Hom.:
AF XY:
AC XY:
27027
AN XY:
49492
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.515 AC: 366350AN: 710750Hom.: 46923 AF XY: 0.517 AC XY: 191570AN XY: 370368
GnomAD4 exome
AF:
AC:
366350
AN:
710750
Hom.:
AF XY:
AC XY:
191570
AN XY:
370368
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.680 AC: 101929AN: 149830Hom.: 34426 Cov.: 0 AF XY: 0.676 AC XY: 49371AN XY: 73020
GnomAD4 genome
AF:
AC:
101929
AN:
149830
Hom.:
Cov.:
0
AF XY:
AC XY:
49371
AN XY:
73020
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 12, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 03, 2021 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 11, 2018 | - - |
Retinitis Pigmentosa, Recessive Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Retinitis pigmentosa Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at